The inflammatory bowel disease (IBD), develops due to an incurable autoimmune liver disease called primary sclerosing ...

A recent major OECD report has warned of a looming crisis in the European health workforce. In the third in our series on the ...

Bill Holdings tried to break out ahead of earnings. The IBD 50 stock plunged 30% on earnings on Friday, triggering a sell ...

For older adults with inflammatory bowel disease (IBD), there was no significant difference in the risk of major ...

IBD Aware, a wearable medical device in development for patients with inflammatory bowel disease, aims to improve disease ...

Patient activation, earned trust and health literacy at patient, provider and health system levels are critical to overcoming ...

As Palantir continues to soar, industry peer Samsara is in big demand as the stock takes aim at fresh breakout.

The Financial Select Sector SPDR Fund ETF trades in a buy zone as XLF holdings Berkshire Hathaway, Visa, Mastercard, JPMorgan ...

Construction materials supplier CRH cleared a buy point Thursday after announcing plans to unload its stake in SigmaRoc.

SAN FRANCISCO -- Janus kinase (JAK) inhibitors appeared to be a safe, effective option for treating inflammatory bowel ...

Researchers from The Institute of Cancer Research in London have developed a new test that can predict colorectal cancer risk ...

A new method for detecting bowel cancer is more than 90% accurate at predicting which higher-risk people will develop the ...